Boğmacada Korunma Prensipleri

Year 2014, , 52 - 59, 01.04.2014

Gülçin Otar İsmail Yıldız Ayşe Kılıç Muhammet Ali Varkal Esra Devecioğlu

https://doi.org/10.5222/j.child.2014.052

Abstract

Boğmaca, bulaşıcı olan ve yaşamı tehdit edebilen bir solu- num yolu hastalığıdır. Aşılamaya rağmen, tüm dünyada sütçocukları, çocuklar ve ergenlerde önemli oranda morbi- dite ve mortaliteye neden olmaya devam etmektedir. Bu makalede boğmaca hastalığının korunma stratejileri göz- den geçirilmiştir

Keywords

Boğmaca, öksürük, çocuk, boğmaca aşısı

Principles of Protection from Whooping Cough

Abstract

Whooping cough is a contagious, and life-threatening res- piratory tract illness. Despite vaccination pertussis has re-emerged worldwide as a cause of morbidity and morta- lity in infants, children, and adolescents. In this article the prevention strategies of pertussis were discussed

Keywords

Pertussis, cough, child, pertussis vaccine

References

• Edwards KM, Decker MD. Pertussisvaccine.In: Plotkin S, Orenstein WA, ed. Vaccines, Philadelphia, PA: Saunders; :471-528. maternal immunization. Vaccine 2003;21:3483-6. http://dx.doi.org/10.1016/S0264-410X(03)00356-6 antibodies in maternal delivery, cord, and infant serum. J Infect Dis 2004;190(2):335-40. http://dx.doi.org/10.1086/421033 of pertussis antibody in the infant and effect on vaccine res- ponse. J Infect Dis 1990;161(3):487-92. http://dx.doi.org/10.1093/infdis/161.3.487
• Bennet JE and Dolin R (eds) Mandell, Douglas and Bennett’s Principles and Practise of Infectious Diseases. 7th ed. Philedephia: Churchill Livingstone Elsevier, 2010; 2955-2964. http://dx.doi.org/10.1016/b978-0-443-06839-3.00230-7
• Munoz M. Pertussis infants, children and adolescents: Diagnosis, treatment, and prevention. Semin Pediatr Infect Dis 2006;17:14-9. http://dx.doi.org/10.1053/j.spid.2005.11.005
• HB, ed. Nelson Textbook of Pediatrics. 18th ed. Saunders: Philadelphia; 2007:1178-82.
• Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005;24:858-61. http://dx.doi.org/10.1097/01.inf.0000160914.59160.41
• Mattoo S, cherry JD. Molecular pathogenesis, epidemio- logy, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rew 2005;18:326-82. http://dx.doi.org/10.1128/CMR.18.2.326-382.2005 diagnosis, management and prevention. Paediatr Respir Rev ;9:201-12. http://dx.doi.org/10.1016/j.prrv.2008.05.010 nation for adolescents and adults, Expert Opin Biol Ther ;4(10):1669-76. http://dx.doi.org/10.1517/14712598.4.10.1669
• Pediatr Clin North Am 2000;47:309-35. http://dx.doi.org/10.1016/S0031-3955(05)70209-1
• Kerr Jr, Matthew rc. Bordetella pertussis infection: patho- genesis, diagnosis, management and the role of protective immunity. Eur J Clin Microbiol Infect Dis 2000;19:77-88. http://dx.doi.org/10.1007/s100960050435 cherry JD, Brunnel PA, Goldon GB, Korzon DT. Report of the task force an pertussis and pertussis immunization. Pediatrics 1988;939-84.
• Krugman’s Infectious Disease of Children. 11th ed. St Loui: Mosby. 2004;335-350. pertussis to vaccination:a cause for its reemergence? Emerg Infect Dis 2001;7:526-8. http://dx.doi.org/10.3201/eid0707.017708 önemi, 87-97. ;25(Ek 2):212-7.
• Pertussis. Pediatr Infect Dis 2005;24:10-8. http://dx.doi.org/10.1097/01.inf.0000160708.43944.99
• Güriş D, Strebel PM, Bardenheier B et al. Changing epide- miology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996, Clin Infect Dis 1999;28(6):1230-7. http://dx.doi.org/10.1086/514776 tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults. JAMA 2005;293:3003-11. http://dx.doi.org/10.1001/jama.293.24.3003
• Greenberg D, Guiso N, et al. Global Pertussis Initiative. New pertussis vaccination strategies beyond infancy: recommenda- tions by the global pertussis initiative. Clin Infect Dis ;39(12):1802. antibody titers of pertussis in Turkey: reflection of circulating microorganism and a threat to infants. Journal of Clinical
• Laboratory Analysis 2007;21:154-61. http://dx.doi.org/10.1002/jcla.20127 gelişmeler. Çocuk Sağlığı ve Hastalıkları Dergisi 2008;51: 75. sis epidemiology in Turkey. Eur J Clin Infect Dis 2008;27:335- http://dx.doi.org/10.1007/s10096-007-0442-x
• Genişletilmiş Bağışıklama Programı Genelgesi: 13.03.2009/ , http://www.saglik.gov.tr/TR/dosya/1-44926/h/gbp- genelgesi-2009.doc ANKEM Derg 2012;26(Ek 2):61-3. national immunization program, Turk J Pediatr 2010;52(6): 9. recommendations for use of tetanus toxoid, reduced diphteria toxoid, and acellular pertussis (Tdap) vaccine from advisory commitee on immunization practices, 2010. MMWR Morb Mortal Wkly Rep 2011;60(1):13-5. vaccination: Computer simulations of five new strategies, Vaccine 2004;22(23-24):3154-65. http://dx.doi.org/10.1016/j.vaccine.2004.01.067
• Committee on Immunization Practices. Provisional recommen- dations for health care personel on use of tetanus toxoid. Reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) and use of postexposure antimicrobial prophylaxis. Date of posting of provisional recommendations, April 4 (2011).
• Gall SA. Vaccines for pertussis and influenza: recommendati- ons for use in pregnancy. Clin Obstet Gynecol 2008;51:486- http://dx.doi.org/10.1097/GRF.0b013e318181dde1 with tetanusdiphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol ;204:334 e1-e5. ponses in infants whose mothers received tdap vaccine during pregnancy. The Pediatric Infectious Disease Journal, ;32(11):1257-60. http://dx.doi.org/10.1097/INF.0b013e3182a09b6a
• Mooi Fr, de Greeff Sc. The case for maternal vaccination against pertussis. Lancet Infect Dis 2007;7:614-24. http://dx.doi.org/10.1016/S1473-3099(07)70113-5 infants: preventing deaths and hospitalisations in the very young. Paedtr Child Health 2008;44:161-5. http://dx.doi.org/10.1111/j.1440-1754.2008.01292.x
• Transmission of Bordetella pertussis to young infants. The Pediatr Infect Dis J 2007;26(4):293-9. http://dx.doi.org/10.1097/01.inf.0000258699.64164.6d
• Bisgard KM, Pascual FB, Ehresmann Kr et al. Infant per- tussis: who was the source? Pediatr Infect Dis J 2004;23(11): 9. http://dx.doi.org/10.1097/01.inf.0000145263.37198.2b
• MJ. Cost-effectiveness analysis of various pertussis vaccina- tion strategies primarily aimed at protecting infants in the Netherlands. Clin Ther 2010;32:1479-95. http://dx.doi.org/10.1016/j.clinthera.2010.07.017
• Nguyen VH. Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation inclu- ding the dynamic population effects. PLoS One 2009; :e6284. http://dx.doi.org/10.1371/journal.pone.0006284 committee on ımmunization Practices (AcıP) centers for
• Disease control and Prevention (cDc). Prevention of per- tussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP) [published correction appears in MMWR Recomm Rep 2008;57(26):723].
• MMWR Recomm Rep 2008;57(RR-4):1-51.
• S. Prevention of pertussis: recommendations derived from the second global pertussis Initiative roundtable meeting. Vaccine ;25:2634-42. http://dx.doi.org/10.1016/j.vaccine.2006.12.017
• Meeting report from the fourth regional roundtable meeting, France, April (2010), Hum Vaccin 2011;7(4):481-8. http://dx.doi.org/10.4161/hv.7.4.14528